标题
The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis
作者
关键词
-
出版物
Journal of Inflammation Research
Volume Volume 15, Issue -, Pages 3847-3858
出版商
Informa UK Limited
发表日期
2022-07-07
DOI
10.2147/jir.s370483
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of Inflammation in the Pathogenesis of Atrial Fibrillation
- (2022) Kensuke Ihara et al. Frontiers in Physiology
- Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism
- (2021) Xin Zhang et al. CELL BIOLOGY AND TOXICOLOGY
- NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias
- (2021) Larry Scott Jr et al. CARDIOVASCULAR RESEARCH
- Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2021) Tiffany M. Powell-Wiley et al. CIRCULATION
- Vincristine attenuates cardiac fibrosis through inhibiting activation of NLRP3 inflammasome
- (2021) Chenliang Ge et al. CLINICAL SCIENCE
- Hydrogen gas inhalation alleviates myocardial ischemia-reperfusion injury by the inhibition of oxidative stress and NLRP3-mediated pyroptosis in rats
- (2021) Chaoqun Nie et al. LIFE SCIENCES
- The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
- (2021) Trevor P. Fidler et al. NATURE
- Gasdermin D in pyroptosis
- (2021) Brandon Burdette et al. Acta Pharmaceutica Sinica B
- NLRP3-mediated pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin
- (2021) Rongchuan Yue et al. Cell Death Discovery
- Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation
- (2021) Si-lin Lv et al. ACTA PHARMACOLOGICA SINICA
- Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies
- (2021) Mengrui Liu et al. ADVANCED DRUG DELIVERY REVIEWS
- Role of obesity and hypertension in the incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
- (2021) Lucia La Sala et al. Cardiovascular Diabetology
- Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways
- (2021) Jianping Yao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Atrial Fibrillation
- (2021) Jayson R. Baman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hydrogen gas inhalation ameliorates cardiac remodelling and fibrosis by regulating NLRP3 inflammasome in myocardial infarction rats
- (2021) Chaoqun Nie et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ
- (2021) Jing Cai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Emodin alleviates LPS ‐induced myocardial injury through inhibition of NLRP3 inflammasome activation
- (2021) Shanshan Dai et al. PHYTOTHERAPY RESEARCH
- Emodin - A natural anthraquinone derivative with diverse pharmacological activities
- (2021) Ruchi Badoni Semwal et al. PHYTOCHEMISTRY
- Cardiac Fibroblast Diversity
- (2020) Michelle D. Tallquist Annual Review of Physiology
- Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure
- (2020) Nikole J. Byrne et al. Circulation-Heart Failure
- Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR‐141‐mediated NLRP3 inflammasome and TGF‐β1/Smads signaling in diabetic cardiomyopathy
- (2020) Hui Che et al. FASEB JOURNAL
- Advances in Synthesis of π-Extended Benzosilole Derivatives and Their Analogs
- (2020) Tuan Thanh Dang et al. MOLECULES
- Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis
- (2020) Anita A. Pinar et al. PHARMACOLOGY & THERAPEUTICS
- NEK7: a potential therapy target for NLRP3-related diseases
- (2020) Ganglei Liu et al. BioScience Trends
- Crosstalks between inflammasome and autophagy in cancer
- (2020) Chaeuk Chung et al. Journal of Hematology & Oncology
- Golgi Apparatus: An Emerging Platform for Innate Immunity
- (2020) Ye Tao et al. TRENDS IN CELL BIOLOGY
- Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis
- (2020) Suwen Chen et al. Journal of the American Heart Association
- The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice
- (2020) Ri-Feng Gao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Chlorogenic Acid Alleviates Hyperglycemia‐Induced Cardiac Fibrosis through Activation of the NO/cGMP/PKG Pathway in Cardiac Fibroblasts
- (2020) Linhui Qin et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Knockdown of dual oxidase 1 suppresses activin A-induced fibrosis in cardiomyocytes via the reactive oxygen species-dependent pyroptotic pathway
- (2020) Shengwei Li et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cardiac fibrosis: potential therapeutic targets
- (2019) Shuin Park et al. Translational Research
- The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse
- (2019) Stefano Toldo et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The Evolution and Biocatalysis of FAD2 Indicate Its Correlation to the Content of Seed Oil in Plants
- (2019) Man Zhao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Innate immunity to intracellular LPS
- (2019) Vijay A. K. Rathinam et al. NATURE IMMUNOLOGY
- The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
- (2019) Nathan Kelley et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction
- (2019) Rifeng Gao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review
- (2019) Danbin Wu et al. INFLAMMATION
- Anakinra in children and adults with Still’s disease
- (2019) Sebastiaan J Vastert et al. RHEUMATOLOGY
- Huoxue Qianyang decoction ameliorates cardiac remodeling in obese spontaneously hypertensive rats in association with ATF6-CHOP endoplasmic reticulum stress signaling pathway regulation
- (2019) Xunjie Zhou et al. BIOMEDICINE & PHARMACOTHERAPY
- Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts
- (2019) Felipe Tapia Cáceres et al. FASEB JOURNAL
- Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function
- (2018) Jonathon P. Audia et al. BASIC RESEARCH IN CARDIOLOGY
- The SGK1 inhibitor EMD638683, prevents Angiotensin II–induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
- (2018) Wenqiang Gan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
- (2018) Chunxia Yao et al. CIRCULATION
- Inflammatory Mechanisms of Cardiovascular Remodeling
- (2018) Toshihisa Anzai CIRCULATION JOURNAL
- Colchicine in Gout: An Update
- (2018) Tristan Pascart et al. CURRENT PHARMACEUTICAL DESIGN
- Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
- (2018) Yi Huang et al. EMBO Molecular Medicine
- Anakinra for the treatment of rheumatoid arthritis: a safety evaluation
- (2018) Julio Ramírez et al. Expert Opinion On Drug Safety
- Periodontal Disease, Systemic Inflammation and the Risk of Cardiovascular Disease
- (2018) Edgar Francisco Carrizales-Sepúlveda et al. Heart Lung and Circulation
- Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation
- (2018) Hailong Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose
- (2018) Xiaohui Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
- (2018) Arpeeta Sharma et al. Frontiers in Physiology
- Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
- (2018) Nikolaos G. Frangogiannis MOLECULAR ASPECTS OF MEDICINE
- Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
- (2018) Luigi Ferrucci et al. Nature Reviews Cardiology
- Control of Inflammasome Activation by Phosphorylation
- (2018) Tao Gong et al. TRENDS IN BIOCHEMICAL SCIENCES
- Brefeldin A–sensitive ER-Golgi vesicle trafficking contributes to NLRP3-dependent caspase-1 activation
- (2018) Sujeong Hong et al. FASEB JOURNAL
- Cholesterol Homeostatic Regulator SCAP-SREBP2 Integrates NLRP3 Inflammasome Activation and Cholesterol Biosynthetic Signaling in Macrophages
- (2018) Chuansheng Guo et al. IMMUNITY
- Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-β1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats
- (2018) Huiliang Qiu et al. PHYTOMEDICINE
- Role of pyroptosis in cardiovascular diseases
- (2018) Chang Jia et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
- (2017) Hadi Khalil et al. JOURNAL OF CLINICAL INVESTIGATION
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gasdermins: Effectors of Pyroptosis
- (2017) Stephen B. Kovacs et al. TRENDS IN CELL BIOLOGY
- IL-1 family cytokines in cardiovascular disease
- (2017) Susanne Pfeiler et al. CYTOKINE
- NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
- (2016) Ø. Sandanger et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration
- (2016) Virpi Talman et al. CELL AND TISSUE RESEARCH
- The Biological Basis for Cardiac Repair After Myocardial Infarction
- (2016) Sumanth D. Prabhu et al. CIRCULATION RESEARCH
- The Emerging Role of Thioredoxin-Interacting Protein in Myocardial Ischemia/Reperfusion Injury
- (2016) Bing F. Wang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation
- (2016) Deepika Sharma et al. JOURNAL OF CELL BIOLOGY
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4/6-IRAK4/1 signaling to suppress NLRP3 inflammasome activation
- (2016) Lin-Lin Kang et al. Scientific Reports
- Molecular mechanisms regulating NLRP3 inflammasome activation
- (2015) Eun-Kyeong Jo et al. Cellular & Molecular Immunology
- ROS and Autophagy: Interactions and Molecular Regulatory Mechanisms
- (2015) Lulu Li et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes
- (2015) Elza Muscelli et al. DIABETOLOGIA
- NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5
- (2015) Paul J. Baker et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Inflammation and the pathogenesis of atrial fibrillation
- (2015) Yu-Feng Hu et al. Nature Reviews Cardiology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiac fibroblasts as sentinel cells in cardiac tissue: Receptors, signaling pathways and cellular functions
- (2015) G. Díaz-Araya et al. PHARMACOLOGICAL RESEARCH
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart
- (2014) Stefano Toldo et al. CARDIOVASCULAR RESEARCH
- Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
- (2014) Alvin Lu et al. CELL
- Mitochondrial NLRP3 Protein Induces Reactive Oxygen Species to Promote Smad Protein Signaling and Fibrosis Independent from the Inflammasome
- (2014) Nathan A. Bracey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome
- (2014) Hao Xu et al. NATURE
- Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine
- (2014) Shigeo Ohta PHARMACOLOGY & THERAPEUTICS
- NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
- (2014) Beibei Luo et al. PLoS One
- Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
- (2013) Beibei Luo et al. CARDIOVASCULAR DRUGS AND THERAPY
- The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
- (2013) Øystein Sandanger et al. CARDIOVASCULAR RESEARCH
- The pathogenesis of cardiac fibrosis
- (2013) Ping Kong et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- Early and Delayed Tranilast Treatment Reduces Pathological Fibrosis Following Myocardial Infarction
- (2012) Fiona See et al. Heart Lung and Circulation
- Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines
- (2012) TAO CHENG et al. Molecular Medicine Reports
- The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases
- (2012) Chul-Su Yang et al. International Neurourology Journal
- Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action
- (2011) C Marques-da-Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Autophagy: Renovation of Cells and Tissues
- (2011) Noboru Mizushima et al. CELL
- Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
- (2011) Masanori Kawaguchi et al. CIRCULATION
- Understanding the mechanism of IL-1β secretion
- (2011) Gloria Lopez-Castejon et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Canakinumab
- (2010) Eugen Dhimolea mAbs
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria
- (2010) Edward A Miao et al. NATURE IMMUNOLOGY
- Regulation and Function of NF-κB Transcription Factors in the Immune System
- (2009) Sivakumar Vallabhapurapu et al. Annual Review of Immunology
- Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
- (2009) T. H. Mogensen CLINICAL MICROBIOLOGY REVIEWS
- Cardiac fibroblasts: At the heart of myocardial remodeling
- (2009) Karen E. Porter et al. PHARMACOLOGY & THERAPEUTICS
- Cardiac Plasticity
- (2008) Joseph A. Hill et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started